References
- 1
Moreto M.
Diagnosis of esophagogastric tumors.
Endoscopy.
2003;
35
36-42
- 2
Fockens P.
Future developments in endoscopic imaging.
Best Pract Res Clin Gastroenterol.
2002;
16
999-1012
- 3
Tajiri H, Matsuda K, Fujisaki J.
What can we see with the endoscope? Present status and perspectives.
Dig Endosc.
2002;
14
131-137
- 4
Haringsma J.
Barrett’s oesophagus: new diagnostic and therapeutic techniques.
Scand J Gastroenterol Suppl.
2002;
37
9-14
- 5
Endo T, Awakawa T, Takahashi H. et al .
Classification of Barrett’s epithelium by magnifying endoscopy.
Gastrointest Endosc.
2002;
55
641-647
- 6
Guelrud M, Herrera I, Essenfeld H. et al .
Intestinal metaplasia of the gastric cardia: a prospective study with enhanced magnification
endoscopy.
Am J Gastroenterol.
2002;
97
584-589
- 7
Kiesslich R, Jung M.
Magnification endoscopy: does it improve mucosal surface analysis for the diagnosis
of gastrointestinal neoplasias?.
Endoscopy.
2002;
34
819-822
- 8
Kumagai Y, Inoue H, Nagai K. et al .
Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture
of superficial esophageal carcinoma.
Endoscopy.
2002;
34
369-375
- 9
Tajiri H, Doi T, Endo H. et al .
Routine endoscopy using a magnifying endoscope for gastric cancer diagnosis.
Endoscopy.
2002;
34
772-777
- 10
Connor M J, Sharma P.
Chromoendoscopy and magnification endoscopy in Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
269-277
- 11
Dinis-Ribeiro M, da Costa-Pereira A, Lopes C. et al .
Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and
dysplasia.
Gastrointest Endosc.
2003;
57
498-504
- 12
Lambert R, Rey J F, Sankaranarayanan R.
Magnification and chromoscopy with the acetic acid test.
Endoscopy.
2003;
35
437-445
- 13
Sharma P, Weston A P, Topalovski M. et al .
Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia
in Barrett’s oesophagus.
Gut.
2003;
52
24-27
- 14
Nakamura K.
Development of real-time endoscopic image processing technology: adaptive index of
hemoglobin color enhancement processing.
Dig Endosc.
2002;
14
S40-S47
- 15
Brand S, Wang T D, Schomacker K T. et al .
Detection of high-grade dysplasia in Barrett’s esophagus by spectroscopy measurement
of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Gastrointest Endosc.
2002;
56
479-487
- 16
Keller R, Winde G, Terpe H J. et al .
Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic
antigen in patients with colorectal carcinoma and adenoma.
Endoscopy.
2002;
34
801-807
- 17
Messmann H, Endlicher E, Gelbmann C M. et al .
Fluorescence endoscopy and photodynamic therapy.
Dig Liver Dis.
2002;
34
754-761
- 18
Ell C.
Improving endoscopic resolution and sampling: fluorescence techniques.
Gut.
2003;
52 (Suppl 4)
30-33
- 19
Georgakoudi I, Van Dam J.
Characterization of dysplastic tissue morphology and biochemistry in Barrett’s esophagus
using diffuse reflectance and light scattering spectroscopy.
Gastrointest Endosc Clin N Am.
2003;
13
297-308
- 20
Kendall C, Stone N, Shepherd N. et al .
Raman spectroscopy, a potential tool for the objective identification and classification
of neoplasia in Barrett’s oesophagus.
J Pathol.
2003;
200
602-609
- 21
Ortner M A, Ebert B, Hein E. et al .
Time gated fluorescence spectroscopy in Barrett’s oesophagus.
Gut.
2003;
52
28-33
- 22
Pfefer T J, Paithankar D Y, Poneros J M. et al .
Temporally and spectrally resolved fluorescence spectroscopy for the detection of
high grade dysplasia in Barrett’s esophagus.
Lasers Surg Med.
2003;
32
10-16
- 23
Weissleder R, Ntziachristos V.
Shedding light onto live molecular targets.
Nat Med.
2003;
9
123-128
- 24
Wong Kee Song L M, Marcon N E.
Fluorescence and Raman spectroscopy.
Gastrointest Endosc Clin N Am.
2003;
13
279-296
- 25
Mataki N, Nagao S, Kawaguchi A. et al .
Clinical usefulness of a new infrared videoendoscope system for diagnosis of early
stage gastric cancer.
Gastrointest Endosc.
2003;
57
336-342
- 26
Owens M M, Kimmey M B.
The role of endoscopic ultrasound in the diagnosis and management of Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
325-334
- 27
Yasuda K.
Endoscopic ultrasonography in Japan and the rest of the world.
Dig Endosc.
2002;
14
S18-S20
- 28
Hunerbein M, Ulmer C, Handke T. et al .
Endosonography of upper gastrointestinal tract cancer on demand using miniprobes or
endoscopic ultrasound.
Surg Endosc.
2003;
17
615-619
- 29
Murata Y, Napoleon B, Odegaard S.
High-frequency endoscopic ultrasonography in the evaluation of superficial esophageal
cancer.
Endoscopy.
2003;
35
429-435
- 30
Sabet E A, Okai T, Minamoto T. et al .
Visualizing the gastric wall with a 30-MHz ultrasonic miniprobe: ex vivo imaging of
normal gastric sites and sites of early gastric cancer.
Abdom Imaging.
2003;
28
252-256
- 31
Poneros J M, Nishioka N S.
Diagnosis of Barrett’s esophagus using optical coherence tomography.
Gastrointest Endosc Clin N Am.
2003;
13
309-323
- 32
Cilesiz I, Fockens P, Kerindongo R. et al .
Comparative optical coherence tomography imaging of human esophagus: how accurate
is localization of the muscularis mucosae?.
Gastrointest Endosc.
2002;
56
852-857
- 33
Taniere P, Borghi-Scoazec G, Saurin J C. et al .
Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative
study of adenocarcinomas of the distal esophagus and of the proximal stomach.
Am J Surg Pathol.
2002;
26
1213-1221
- 34
Morales C P, Spechler S J.
Intestinal metaplasia at the gastroesophageal junction: Barrett’s, bacteria, and biomarkers.
Am J Gastroenterol.
2003;
98
759-762
- 35
Reid B J, Blount P L, Rabinovitch P S.
Biomarkers in Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
369-397
- 36
Jenkins G J, Doak S H, Griffiths A P. et al .
Early p53 mutations in nondysplastic Barrett’s tissue detected by the restriction
site mutation (RSM) methodology.
Br J Cancer.
2003;
88
1271-1276
- 37
Mahmood U, Weissleder R.
Near-infrared optical imaging of proteases in cancer: near-infrared optical imaging
of proteases in cancer.
Mol Cancer Ther.
2003;
2
489-496
- 38
Kouklakis G S, Kountouras J, Dokas S M. et al .
Methylene blue chromoendoscopy for the detection of Barrett’s esophagus in a Greek
cohort.
Endoscopy.
2003;
35
383-387
- 39
Olliver J R, Wild C P, Sahay P. et al .
Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s oesophagus.
Lancet.
2003;
362
373-374
- 40
Yoshida T, Inoue H, Hara E. et al .
Newly developed 3D endoscopic system: preliminary experience.
Endoscopy.
2003;
35
181-184
- 41
Cameron A J, Souto E O, Smyrk T C.
Small adenocarcinomas of the esophagogastric junction: association with intestinal
metaplasia and dysplasia.
Am J Gastroenterol.
2002;
97
1375-1380
- 42
Nakamura T, Ide H, Eguchi R. et al .
Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire
on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
Dis Esophagus.
2002;
15
219-225
- 43
Ichikura T, Ogawa T, Kawabata T. et al .
Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial
carcinoma?.
World J Surg.
2003;
27
334-338
- 44
Lightdale C J, Lambert R.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus,
stomach, and colon.
Gastrointest Endosc.
2003;
58 (6 Suppl)
S1
- 45
Dixon M F.
Gastrointestinal epithelial neoplasia: Vienna revisited.
Gut.
2002;
51
130-131
- 46
Kodama M, Kakegawa T.
Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire
on superficial cancer of the esophagus in Japan.
Surgery.
1998;
123
432-439
- 47
Spechler S J.
The natural history of dysplasia and cancer in esophagitis and Barrett esophagus.
J Clin Gastroenterol.
2003;
36 (Suppl)
S2-S5
- 48
Dar M S, Goldblum J R, Rice T W. et al .
Can extent of high grade dysplasia in Barrett’s oesophagus predict the presence of
adenocarcinoma at oesophagectomy?.
Gut.
2003;
52
486-489
- 49
National Report of the Medical Examination for Digestive Cancer Group.
1999 [in Japanese].
J Gastroenterol Mass Surv.
2002;
40
57-76
- 50
Fennerty M B.
Endoscopic diagnosis and surveillance of Barrett’s esophagus.
Gastrointest Endosc Clin N Am.
2003;
13
257-267
R. Lambert, M. D.
International Agency for Research on Cancer
150, cours Albert Thomas · Lyon 69372, Cedex 8 · France
Fax: +33-4-72738650
Email: lambert@iarc.fr
